Frontiers in Pharmacology | Renal Pharmacology

Review

Published on 07 Jan 2025

Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target

in Renal Pharmacology

Yan Li
Yuxin Zhang
Mengxia Cao
Tingting Yuan
Santao Ou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1475198

1,887 views
1 citation

Original Research

Published on 07 Jan 2025

High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury

in Renal Pharmacology

Sayantap Datta
Mohammad Atiqur Rahman
Saisudha Koka
Krishna M. Boini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1540639

2,924 views
3 citations

Correction

Published on 06 Jan 2025

Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation

in Renal Pharmacology

Guangzhuang Li
Sentao Xian
Xianchao Cheng
Yunhua Hou
Wenqing Jia
Yukui Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1548193

940 views

Original Research

Published on 06 Jan 2025

Curcumin nanocrystals ameliorate ferroptosis of diabetic nephropathy through glutathione peroxidase 4

in Renal Pharmacology

Mengjiao Xue
Yiwei Tian
Hua Zhang
Shijie Dai
Yangsheng Wu
Juan Jin
Jian Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1508312

1,645 views

Original Research

Published on 06 Jan 2025

The efficacy and safety of half-dose glucocorticoids combined with rituximab versus high-dose glucocorticoids for initial treatment of minimal change disease: a single-center experience

in Renal Pharmacology

Xueting Li
Peng Yan
Lu Zhang
Wei Qiao
Zhengbiao Xue
Xiangdong Fang
Ben Ke
Shuying Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403562

1,275 views
2 citations

Systematic Review

Published on 03 Jan 2025

Protective effects and possible mechanisms of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles against kidney fibrosis in animal models: a systematic review and meta-analysis

in Renal Pharmacology

Yuanchen Lv
Zibo Hua
Xiaomei Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1511525

2,547 views

Original Research

Published on 03 Jan 2025

FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle

in Renal Pharmacology

Yudie Zhang
Fan Wang
Chongyang Zhang
Fan Yao
Bin Zhang
Yongping Zhang
Xiaobo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500458

1,838 views

Original Research

Published on 03 Jan 2025

Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats

in Renal Pharmacology

Sung-Ok Kim
Arin Choi
Hee-Hwan Lee
Jae-Yong Lee
Sang Jae Park
Byung-Hak Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485072

1,468 views

Original Research

Published on 18 Dec 2024

Immunosuppressant nonadherence profile in kidney transplant recipients and the impact of medication adherence on transplant outcomes

in Renal Pharmacology

Zou Zhi-yu
Dai Lin-rui
Yu Chen-zhen
Chen Ren-jie
Yu Fei-hong
Chen Song
Chang Sheng
Zhang Wei-jie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1493166

1,249 views
1 citation

Original Research

Published on 18 Dec 2024

An exploratory study evaluated the 30 most commonly reported medications in the United States food and drug administration’s adverse event reporting system that are associated with the occurrence of kidney stones

in Renal Pharmacology

Erhao Bao
Yang Yang
Binglei Jiang
Ben Wang
Ying Liu
Lin Yang
Long Xia
Pingyu Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377679

2,753 views

Original Research

Published on 18 Dec 2024

PM2.5-induced oxidative stress upregulates PLA2R expression in the lung and is involved in the pathogenesis of membranous nephropathy through extracellular vesicles

in Renal Pharmacology

Wang Zhang
Jiating Chen
Ye Yuan
Jiao Luo
Zhanmei Zhou
Guobao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1516111

1,639 views
2 citations

Original Research

Published on 16 Dec 2024

Ondansetron use is associated with increased risk of acute kidney injury in ICU patients following cardiac surgery: a retrospective cohort study

in Renal Pharmacology

Feiyi Xu
Xun Gong
Wei Chen
Xiaomin Dong
Jiang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1511545

2,284 views

Original Research

Published on 12 Dec 2024

JiangyaTongluo decoction ameliorates tubulointerstitial fibrosis via regulating the SIRT1/PGC-1α/mitophagy axis in hypertensive nephropathy

in Renal Pharmacology

Yun Zhao
Qi Jia
Gaimei Hao
Lin Han
Yushan Gao
Xiaoyu Zhang
Ziming Yan
Boyang Li
Yiping Wu
Boya Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491315

2,759 views
1 citation

Correction

Published on 12 Dec 2024

Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling

in Renal Pharmacology

Qian Huang
Rui Xiao
Jing Lu
Yao Zhang
Liang Xu
Jie Gao
Jing Sun
Haiping Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1532797

701 views

Editorial

Published on 11 Dec 2024

Editorial: Novel pathophysiologic mechanisms and reno-protective pharmacotherapies in diabetic kidney disease

in Renal Pharmacology

Elias John Elenjickal
Anna T. Valson
Santosh Varughese
Lloyd Vincent
Edwin Fernando
Gopalakrishnan Natarajan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1531748

1,099 views

Original Research

Published on 11 Dec 2024

Hypoalbuminemia and cisplatin-induced acute kidney injury

in Renal Pharmacology

Wen-Jun Yin
Yu-Jie Huang
Qing Zhu
Xiao-Qing Lin
Hui-Ling Piao
Qian-Qian Yu
Chang-Hong Lai
Guang-Liang Zhou
Ling-Yun Zhou
Kun Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1510477

1,312 views